Naltrexone is a long acting opioid receptor antagonist used to treat inflammatory and acantholytic dermatologic conditions at low doses (1 5 mg dose) and itch at both low and higher doses. This study found low dose Success of GLP 1 receptor agonists in kidney disease halts FLOW trial early ADA Meeting News Mechanism of cardiovascular disease benefit of glucagon like peptide 1 agonists. Abstract Europe PMC Simone Biles wins Olympic gold with the vault named after her : NPR Graco Stroller Frames Car Seat Compatible Shop Now Can GLP 1 weight loss drugs help cancer patients? A study shows people diagnosed with certain types of #cancer who later started #GLP1 medications lived longer than patients taking other #diabetes treatments.